Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › LncRNAs for therapy and diagnosis of cardiac hypertrophy

LncRNAs for therapy and diagnosis of cardiac hypertrophy

US Patent 11371043 · Granted Jun 28, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

IncRNAS for therapy and diagnosis of angiogenesis2022
Compound for treatment of heart failure2021
Natural compounds and fibrosis2021
LNCRNA MEG3 for therapy and diagnosis of cardiac remodelling2021
LNCRNA MEG3 for therapy and diagnosis of cardiac remodelling2021
Mitochondrial non-coding RNAs for predicting disease progression in heart failur2020
MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes2019
LncRNAs for therapy and diagnosis of angiogenesis2019
MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes2018
MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes2017
miRNA-212/132 family as a therapeutic target2016
Microrna (miRNA) and downstream targets for diagnostic and therapeutic purposes2015